SEC Form 4 · accession 0002119908-26-000007
BICYCLE THERAPEUTICS PLC · BCYC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Scott Perry
Officer — Chief Operating Officer
Period of report
Jul 2, 2026
Accepted (ET)
Jul 7, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001761612
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Jul 2, 2026 | S | 1,036 | $4.27 | D | 91,428 | D | |
| Ordinary SharesF3 | Jul 6, 2026 | S | 43 | $4.31 | D | 91,385 | D | |
| Ordinary Shares | Jul 6, 2026 | S | 333 | $4.34 | D | 91,052 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.31 inclusive.
- F4This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 27, 2025.